Ignite Creation Date:
2024-05-06 @ 10:43 AM
Last Modification Date:
2024-10-26 @ 12:34 PM
Study NCT ID:
NCT03330405
Status:
TERMINATED
Last Update Posted:
2023-10-13
First Post:
2017-10-16
Brief Title:
Javelin Parp Medley Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors
Sponsor:
Pfizer
Organization:
Pfizer
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced Primary or Recurrent or Metastatic Solid Tumors |
Keywords:
| Name | View |
|---|---|
| NSCLC TNBC hormone receptor positive HR breast cancer recurrent epithelial ovarian cancer UC and castration resistant prostate cancer CRPC | View |